ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

The Cloning Story: How Dolly Made Page 1 And A Physicist Got Air Time

May 15, 1998

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993